Carmen De Mendoza Fernandez-rekin lankidetzan egindako argitalpenak (25)

2024

  1. Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients

    GigaByte, Vol. 2024

  2. Prospects for Controlling Hepatitis B Globally

    Pathogens, Vol. 13, Núm. 4

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy

    Drug Design, Development and Therapy, Vol. 17, pp. 155-166

  3. Genetic signature detected in T cell receptors from patients with severe COVID-19

    iScience, Vol. 26, Núm. 10

  4. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  5. Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain

    Journal of Clinical Virology, Vol. 167

  6. Safety considerations in the management of hepatitis C and HIV co-infection

    Expert Opinion on Drug Safety, Vol. 22, Núm. 5, pp. 363-372

  7. Susceptibility to hepatitis B virus infection in adults living in Spain

    Liver International, Vol. 43, Núm. 5, pp. 1015-1020

  8. Treatment of hepatitis delta and HIV infection

    Liver International, Vol. 43, Núm. S1, pp. 108-115

  9. Viral hepatitis in persons living with HIV in the post-COVID era

    AIDS reviews, Vol. 25, Núm. 1, pp. 1-13

2022

  1. Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies

    Journal of Viral Hepatitis, Vol. 29, Núm. 9, pp. 777-784

  2. Is SARS-CoV-2 the only cause of long-COVID?

    AIDS Reviews, Vol. 24, Núm. 4, pp. 183-196

  3. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network

    International Journal of Infectious Diseases, Vol. 122, pp. 970-975

  4. Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain

    Hepatology International, Vol. 16, Núm. 5, pp. 1161-1169

  5. Pre-Exposure Prophylaxis for viral infections other than HIV

    Infezioni in Medicina, Vol. 30, Núm. 3, pp. 362-371

  6. The unexpected high prevalence of HBV subgenotype D4 in patients with chronic hepatitis B in Galicia, a northwestern Spanish region, reflects strong links with Latin America

    Journal of Clinical Virology, Vol. 153

  7. Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades

    AIDS, Vol. 36, Núm. 2, pp. 249-256

  8. Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases

    Future Microbiology, Vol. 17, Núm. 11, pp. 887-897

2021

  1. Envisioning a hepatitis delta cure with new antivirals

    Future Microbiology, Vol. 16, Núm. 13, pp. 927-930